Schedule a Recheck Visit If youre using a GLP-1 medication or considering one , or if youve noticed changes in energy, muscle tone, or overall wellness during weight loss, we encourage you to schedule a recheck visit
Patients should understand that tirzepatide requires once-weekly subcutaneous injection, with dosing typically starting at 2.5 mg and gradually titrating upward every four weeks (up to 15 mg) to minimize gastrointestinal adverse effects
It replaces the muscle that is normally lost during menopause and weight loss
Key facts CVS Caremark made Wegovy the preferred weight-loss GLP-1 effective July 1, 2025, benefiting Aetna commercial members while Express Scripts (Cigna) excludes it on the base formulary
Continuous use, combined with lifestyle interventions such as diet and exercise, is necessary to maintain weight loss